Advocates for medicines that are unregistered in South Africa have accused the regulatory authority of not being proactive in bringing such products to market and approving their use.
Academic rigour, journalistic flair
Articles on Public health
Displaying 801 - 820 of 2129 articles
A disruption of societal norms created by industry interference is urgently required to create a shift in the food system.
Negotiating for the fair treatment of study participants and benefit sharing before a study commences does not constitute an unfair inducement. It is an ethical imperative.
Ethiopia’s party system is extremely volatile due to the prevalence of weakly institutionalised and fragmented political parties.
Women, particularly those of childbearing age, were more likely to be unsure about getting vaccinated.
Current blood pressure targets are based on information from high-income countries. This might mean that these targets are not ideal for South Africans.
Giving money to support local production of COVID-19 vaccines is a step in the right direction if it will help in resuscitating Nigeria’s vaccine production laboratory.
CC BY-NC-ND15.8 MB (download)
What’s all the excitement around ivermectin? Can it actually help treat COVID-19 patients?
Ghanaian consumption patterns towards fast food are evolving.
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
Nigerian women’s experiences of conflict mirror their unequal status and the prevalence of gender violence in and out of conflict.
Getting pharmacies more involved could be a game changer, particularly for reaching minorities, older adults without internet access and others left behind.
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
CC BY-NC-ND17.6 MB (download)
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
Many of these diseases cause tremendous suffering and death – yet there’s still a lack of effective tools to diagnose, treat, and prevent them.
Studies have shown that highlighting individual responsibility isn’t quite as effective as it seems
History holds some lessons about when scaring people to change their behavior works. Two public health experts offer a case for caution right now.
Almost half of Australian adults struggle with reading. Our recent analysis of government information on COVID-19 found many documents were inaccessible to struggling readers.
Studies in poor countries have highlighted disparities in respectful and responsive care during childbirth based on women’s socioeconomic status and other characteristics.
Workplace-based interventions could make a substantial contribution to reducing the burden of noncommunicable diseases in the country.
Top contributors
-
Emeritus Professor in Public Health, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Research Scientist, African Population and Health Research Center
-
Executive Secretary, Nigerian Academy of Science
-
Medical scientist, National Institute for Communicable Diseases
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Distinguished Professor in the Department of Medicine and Director, The Centre for Medical Ethics & Law, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Fellow, Nigerian Academy of Science
-
Vice Chancellor, University of Global Health Equity
-
Associate Professor, Epidemiology, Deakin University
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
